Bio News
Virginia Tech researchers discovered BMP3, a protein that reverses pulmonary arterial hypertension, a disease with a 50% 5-year survival rate. BMP3 is secreted by pulmonary arterial smooth muscle cells and acts as a “brake” by suppressing excessive proliferation of endothelial cells. The researchers supplemented BMP3 through AAV1 gene therapy, restoring vascular damage in an animal model.
BIOBOOK TEAM
biobookmedia@biobook.co.krRoche’s New Drug for Uveitic Macular Edema Faces FDA Decision in July 2027
BMS Reports Concurrent Phase 3 Success in Idiopathic Pulmonary Fibrosis and Solid Tumors
Merck’s $1.3 trillion eye disease drug raises safety and efficacy concerns: “Limited competitiveness”
CHA Biotech Holds 24.23% Stake in CMG Pharmaceutical as Share Consolidation Reduces Its Share Count
Rural Development Administration Develops Two Molecular Markers to Identify Leaf Splitting in Squash
MFDS Begins Distribution of Internationally Certified Reference Materials, Including 24 New Items, for a Total of 882
